EGFR and cancer: Overexpression, gene amplification, or mutations in EGFR are correlated with poor prognosis and clinical outcome in many types of cancer, such as lung, breast, brain, head and neck, ovarian, cervical, bladder, and esophageal cancer [5,6,7].